Veru Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Income Taxes (Tables)

9 Months Ended

Jun. 30, 2024

	*Three Months Ended*						*Nine Months Ended*
	*June 30,*						*June 30,*
	*2024*			*2023 (Restated)*			*2024*			*2023 (Restated)*

Income tax benefit at U.S. federal statutory rates	$	(2,269,355	)	$	(2,617,670	)	$	(6,089,752	)	$	(17,870,551	)
State income tax benefit, net of federal benefit		(175,713	)		(202,682	)		(471,521	)		(1,383,691	)
Non-deductible expenses		30,038			(262,005	)		291,056			185,564
Effect of stock options exercised		309			—			309			63,849
U.S. research and development tax credit		1,109,784			2,835,378			692,784			415,378
Effect of foreign income tax rates		5,041			406,324			(77,905	)		307,188
Effect of global intangible low taxed income		302,155			(24,691	)		302,155			(24,691	)
Change in valuation allowance		1,157,182			(55,884	)		5,621,937			18,257,505
Other, net		2,981			(21,219	)		2,922			(27,837	)
Income tax expense (benefit)	$	162,422		$	57,551		$	271,985		$	(77,286	)